Nyxoah S.A. (NYXH)
NASDAQ: NYXH · IEX Real-Time Price · USD
9.76
-0.06 (-0.61%)
At close: May 3, 2024, 4:00 PM
10.11
+0.35 (3.60%)
After-hours: May 3, 2024, 4:42 PM EDT
Nyxoah Revenue
In the year 2023, Nyxoah had annual revenue of $4.83M with 47.25% growth. Revenue in the quarter ending December 31, 2023 was $2.03M with 45.76% year-over-year growth.
Revenue (ttm)
$4.83M
Revenue Growth
+47.25%
P/S Ratio
57.90
Revenue / Employee
$33,090
Employees
146
Market Cap
279.74M USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.83M | 1.55M | 47.25% |
Dec 31, 2022 | 3.28M | 2.31M | 238.87% |
Dec 31, 2021 | 968.18K | 884.04K | 1,050.60% |
Dec 31, 2020 | 84.15K | - | - |
Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Vanda Pharmaceuticals | 192.64M |
Xeris Biopharma Holdings | 163.91M |
ChromaDex | 83.57M |
Codexis | 74.23M |
Sanara MedTech | 64.99M |
Poseida Therapeutics | 64.70M |
Opthea | 385.28K |
NYXH News
- 24 days ago - Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer - GlobeNewsWire
- 6 weeks ago - Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation - GlobeNewsWire
- 6 weeks ago - Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints - GlobeNewsWire
- 2 months ago - Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results - GlobeNewsWire
- 2 months ago - Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 2 months ago - Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 - GlobeNewsWire
- 3 months ago - Nyxoah Announces 2024 Strategic Priorities - GlobeNewsWire
- 4 months ago - Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023 - GlobeNewsWire